Ameriprise’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.75M | Sell |
235,065
-18,199
| -7% | -$405K | ﹤0.01% | 2463 |
|
|
2025
Q4 | $4.86M | Sell |
253,264
-20,618
| -8% | -$434K | ﹤0.01% | 2455 |
|
|
2025
Q3 | $6.6M | Sell |
273,882
-68,705
| -20% | -$1.6M | ﹤0.01% | 2217 |
|
|
2025
Q2 | $6.67M | Buy |
342,587
+5,690
| +2% | +$84.1K | ﹤0.01% | 2132 |
|
|
2025
Q1 | $4.33M | Sell |
336,897
-66,830
| -17% | -$1.07M | ﹤0.01% | 2417 |
|
|
2024
Q4 | $6.96M | Sell |
403,727
-50,056
| -11% | -$1M | ﹤0.01% | 2104 |
|
|
2024
Q3 | $10.2M | Buy |
453,783
+116,904
| +35% | +$2.67M | ﹤0.01% | 1770 |
|
|
2024
Q2 | $8.32M | Sell |
336,879
-213,347
| -39% | -$6.06M | ﹤0.01% | 1915 |
|
|
2024
Q1 | $18.1M | Sell |
550,226
-11,675
| -2% | -$397K | 0.01% | 1365 |
|
|
2023
Q4 | $20.4M | Sell |
561,901
-96,275
| -15% | -$3.3M | 0.01% | 1264 |
|
|
2023
Q3 | $24.2M | Buy |
658,176
+346,111
| +111% | +$13.8M | 0.01% | 1102 |
|
|
2023
Q2 | $12M | Buy |
312,065
+3,652
| +1% | +$135K | ﹤0.01% | 1631 |
|
|
2023
Q1 | $12.6M | Buy |
308,413
+35,664
| +13% | +$1.49M | ﹤0.01% | 1589 |
|
|
2022
Q4 | $9.46M | Buy |
272,749
+13,111
| +5% | +$458K | ﹤0.01% | 1786 |
|
|
2022
Q3 | $7.2M | Sell |
259,638
-5,138
| -2% | -$167K | ﹤0.01% | 1953 |
|
|
2022
Q2 | $7.85M | Buy |
264,776
+1,012
| +0.4% | +$34K | ﹤0.01% | 1943 |
|
|
2022
Q1 | $10.8M | Buy |
263,764
+3,185
| +1% | +$137K | ﹤0.01% | 1862 |
|
|
2021
Q4 | $12.5M | Buy |
260,579
+84,810
| +48% | +$3.8M | ﹤0.01% | 1800 |
|
|
2021
Q3 | $7.29M | Sell |
175,769
-15,598
| -8% | -$622K | ﹤0.01% | 2113 |
|
|
2021
Q2 | $8.65M | Sell |
191,367
-20,102
| -10% | -$940K | ﹤0.01% | 2047 |
|
|
2021
Q1 | $9.35M | Buy |
211,469
+6,716
| +3% | +$254K | ﹤0.01% | 1934 |
|
|
2020
Q4 | $7.12M | Sell |
204,753
-109,474
| -35% | -$3.09M | ﹤0.01% | 1999 |
|
|
2020
Q3 | $5.45M | Buy |
314,227
+38,829
| +14% | +$677K | ﹤0.01% | 2010 |
|
|
2020
Q2 | $4.52M | Sell |
275,398
-6,967
| -2% | -$106K | ﹤0.01% | 2135 |
|
|
2020
Q1 | $2.56M | Sell |
282,365
-45,277
| -14% | -$912K | ﹤0.01% | 2344 |
|
|
2019
Q4 | $6.96M | Sell |
327,642
-42,200
| -11% | -$936K | ﹤0.01% | 2015 |
|
|
2019
Q3 | $8.49M | Buy |
369,842
+36,744
| +11% | +$838K | ﹤0.01% | 1832 |
|
|
2019
Q2 | $8.08M | Buy |
333,098
+18,754
| +6% | +$386K | ﹤0.01% | 1893 |
|
|
2019
Q1 | $4.07M | Buy |
314,344
+21,133
| +7% | +$370K | ﹤0.01% | 2351 |
|
|
2018
Q4 | $4.38M | Buy |
293,211
+48,276
| +20% | +$1.25M | ﹤0.01% | 2207 |
|
|
2018
Q3 | $9.63M | Buy |
244,935
+206,359
| +535% | +$9.3M | ﹤0.01% | 1891 |
|
|
2018
Q2 | $1.9M | Sell |
38,576
-1,603
| -4% | -$90.9K | ﹤0.01% | 2758 |
|
|
2018
Q1 | $2.4M | Buy |
40,179
+4,599
| +13% | +$307K | ﹤0.01% | 2628 |
|
|
2017
Q4 | $2.8M | Buy |
35,580
+10,430
| +41% | +$841K | ﹤0.01% | 2479 |
|
|
2017
Q3 | $2.11M | Buy |
25,150
+2,133
| +9% | +$151K | ﹤0.01% | 2583 |
|
|
2017
Q2 | $1.5M | Sell |
23,017
-157,229
| -87% | -$10.7M | ﹤0.01% | 2747 |
|
|
2017
Q1 | $13.1M | Sell |
180,246
-26,468
| -13% | -$1.74M | 0.01% | 1322 |
|
|
2016
Q4 | $12.1M | Buy |
+206,714
| New | +$10.9M | 0.01% | 1373 |
|
Other funds holding ADNT
VPM
WP
Ameriprise's ADNT Position: Q1 2026 in Review
Ameriprise reduced its Adient (ADNT) stake by 7.2% in Q1 2026, selling an estimated $405K and leaving 235,065 shares worth $4.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2463.
Ameriprise first reported a position in ADNT in Q4 2016 and has held it in 38 quarters since. The position peaked at $24.2M in Q3 2023. 286 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.
- Ameriprise held 235,065 shares of Adient worth $4.75M as of Q1 2026.
- Ameriprise sold 18,199 Adient shares in Q1 2026, an estimated $405K.
- Adient made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2463 holding.
- Ameriprise first reported a position in Adient in Q4 2016 and has held it in 38 quarters since.
- Ameriprise's Adient position peaked at $24.2M in Q3 2023.
- 286 funds tracked by Wall St. Rank held Adient as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.